202 related articles for article (PubMed ID: 21707486)
1. Hypoxia-inducible factors and sphingosine 1-phosphate signaling.
Cuvillier O; Ader I
Anticancer Agents Med Chem; 2011 Nov; 11(9):854-62. PubMed ID: 21707486
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia, therapeutic resistance, and sphingosine 1-phosphate.
Cuvillier O; Ader I; Bouquerel P; Brizuela L; Gstalder C; Malavaud B
Adv Cancer Res; 2013; 117():117-41. PubMed ID: 23290779
[TBL] [Abstract][Full Text] [Related]
3. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy.
Ader I; Malavaud B; Cuvillier O
Cancer Res; 2009 May; 69(9):3723-6. PubMed ID: 19383898
[TBL] [Abstract][Full Text] [Related]
4. Targeting sphingosine-1-phosphate in hematologic malignancies.
Stevenson CE; Takabe K; Nagahashi M; Milstien S; Spiegel S
Anticancer Agents Med Chem; 2011 Nov; 11(9):794-8. PubMed ID: 21707492
[TBL] [Abstract][Full Text] [Related]
5. A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma.
Salama MF; Carroll B; Adada M; Pulkoski-Gross M; Hannun YA; Obeid LM
FASEB J; 2015 Jul; 29(7):2803-13. PubMed ID: 25805832
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2.
Anelli V; Gault CR; Cheng AB; Obeid LM
J Biol Chem; 2008 Feb; 283(6):3365-3375. PubMed ID: 18055454
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
Schnitzer SE; Weigert A; Zhou J; Brüne B
Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
[TBL] [Abstract][Full Text] [Related]
8. SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.
Hart PC; Chiyoda T; Liu X; Weigert M; Curtis M; Chiang CY; Loth R; Lastra R; McGregor SM; Locasale JW; Lengyel E; Romero IL
Mol Cancer Res; 2019 Apr; 17(4):870-881. PubMed ID: 30655321
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer.
Bao Y; Guo Y; Zhang C; Fan F; Yang W
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28991193
[TBL] [Abstract][Full Text] [Related]
10. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
11. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
Wang X; Sun Y; Peng X; Naqvi SMAS; Yang Y; Zhang J; Chen M; Chen Y; Chen H; Yan H; Wei G; Hong P; Lu Y
Cancer Control; 2020; 27(1):1073274820976664. PubMed ID: 33317322
[TBL] [Abstract][Full Text] [Related]
12. Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells.
Hafizi R; Imeri F; Stepanovska Tanturovska B; Manaila R; Schwalm S; Trautmann S; Wenger RH; Pfeilschifter J; Huwiler A
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682566
[TBL] [Abstract][Full Text] [Related]
13. FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model.
Gstalder C; Ader I; Cuvillier O
Mol Cancer Ther; 2016 Oct; 15(10):2465-2474. PubMed ID: 27507852
[TBL] [Abstract][Full Text] [Related]
14. Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate.
Hait NC; Maiti A; Xu P; Qi Q; Kawaguchi T; Okano M; Takabe K; Yan L; Luo C
FASEB J; 2020 Mar; 34(3):4293-4310. PubMed ID: 32017264
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1α in Thyroid Follicular Carcinoma Cells.
Kalhori V; Kemppainen K; Asghar MY; Bergelin N; Jaakkola P; Törnquist K
PLoS One; 2013; 8(6):e66189. PubMed ID: 23824493
[TBL] [Abstract][Full Text] [Related]
16. Berberine Preconditioning Protects Neurons Against Ischemia via Sphingosine-1-Phosphate and Hypoxia-Inducible Factor-1[Formula: see text].
Zhang Q; Bian H; Guo L; Zhu H
Am J Chin Med; 2016; 44(5):927-41. PubMed ID: 27430910
[TBL] [Abstract][Full Text] [Related]
17. Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate.
Yasuo M; Mizuno S; Allegood J; Kraskauskas D; Bogaard HJ; Spiegel S; Voelkel NF
PLoS One; 2013; 8(1):e53927. PubMed ID: 23326540
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic properties of sphingosine kinases in haematological malignancies.
Wallington-Beddoe CT; Bradstock KF; Bendall LJ
Br J Haematol; 2013 Jun; 161(5):623-638. PubMed ID: 23521541
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine kinase 1 as an anticancer therapeutic target.
Gao Y; Gao F; Chen K; Tian ML; Zhao DL
Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
